Despite the hype generated by the Genomics revolution, hardly any outputs produced in ‘omics’ research projects actually lead to the development of commercial products. Notable examples of developments that have made it into medical practice are tests such as Oncotype Dx (a 21-gene assay that provides an individualized prediction of chemotherapy benefit) and MammaPrint (a microarray-based gene signature [...]
Search
-
Recent Posts
- Is lack of relevant information the major stumbling block to VC-backed investments in the life science sector in emerging markets?
- What the Vienna Philharmonic Orchestra and biotech innovation have in common…
- Your organisation is supporting innovation. Really…?
- Making (life science) innovation better
- A mega-fund boost to biomedical innovation in Africa
Recent Comments
- Making (life science) innovation better – World Class Biotech. Made in Africa on A mega-fund boost to biomedical innovation in Africa
- Jonathan Blackburn on On ‘omics’ translation and innovation
- On ‘omics’ translation and innovation – World Class Biotech. Made in Africa on Fixes that fail in ‘omics’ research and translation
- Developing a framework for measuring the impact of a biotech social enterprise – Part 2: Publications – World Class Biotech. Made in Africa on Developing a framework for measuring the impact of a biotech social enterprise – Part 1
- Reinhard Hiller on Fixes that fail in ‘omics’ research and translation
Archives
Categories
Meta
Calendar
May 2013 M T W T F S S « Mar 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Pages
Meta
© 2013 World Class Biotech. Made in Africa | Powered by WordPress
A WordPress theme by Ravi Varma